GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
SoftOx secures Irish approval for Phase 1 trial of SIS-02
Avid Bioservices opens new Early Phase Center of Excellence
OrthoTrophix completes patient enrolment in TPX-100 Phase 2b clinical trial
Bloom Science doses first patient in Phase 1b trial of BL-001 for obesity treatment
Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA
Epredia signs EU distribution deal with Mindpeak for AI pathology software
AlzeCure's ACD440 granted EU orphan drug status for erythromelalgia
Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA
Astellas Pharma signs global strategic collaboration with Vir Biotechnology
Illumina sets out 18-Month NovaSeq X roadmap to boost sequencing performance and scale
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
Novo Nordisk's CagriSema achieves 23% weight loss but misses primary endpoint in REDEFINE 4 trial
NICE recommends epcoritamab for relapsed or refractory follicular lymphoma
AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL